Test Overview
Method
High performance liquid chromatography-Tandem mass spectrometry (HPLC-MS/MS)
Result Included
Fluvoxamine
Aliases/Synonyms
Luvox®
Specimen
Specimen Type
Avoid gel separator tubes Serum (Preferred)Plasma (Acceptable)
Containers
Preferred Containers
Red top (no additive)
Acceptable Containers
Lavender top (EDTA)
Volume
Sample Volume
1 mL
Minimum Volume
0.4 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 7 days | 30 days | 365 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Specimen | Gel-separator tubes or Room Temp. |
Performance & Interpretation
Turnaround Time
10 days
Results
Name
Units
Reference Range
Conversion
-
Fluvoxamineng/mL
Comment
Steady-state plasma levels following a daily regimen
of 150 to 300 mg/day: 78-920 ng/mL (mean 510)
Reporting limit: 10
Test performed at: NMS Labs, 200 Welsh Rd, Horsham, PA 19044-2208
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| FLUVOX SP | FLUVOXAMINE, SERUM/PLASMA | 64805 | ng/mL |
Test Version
Last Updated
2023-03-23